First patients test new hope for Tough-to-Treat blood cancer
NCT ID NCT04000282
Summary
This study was the first time a new drug called SAR442085 was tested in people. It aimed to find a safe dose and see if it could help control multiple myeloma, a type of blood cancer, in patients whose disease had come back or stopped responding to many other standard treatments. The trial involved 37 adults with advanced disease to check for side effects and early signs of anti-cancer activity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMA CELL MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope Site Number : 8400002
Duarte, California, 91010, United States
-
Dana Farber Cancer Institute Site Number : 8400003
Boston, Massachusetts, 02115, United States
-
Froedtert Hospital & Medical College of Wisconsin Site Number : 8400004
Milwaukee, Wisconsin, 53226, United States
-
Investigational Site Number : 1580001
Taipei, 10002, Taiwan
-
Investigational Site Number : 2030001
Prague, 12808, Czechia
-
Investigational Site Number : 2030002
Brno, 62500, Czechia
-
Investigational Site Number : 2030003
Ostrava - Poruba, 70852, Czechia
-
Investigational Site Number : 2500001
Toulouse, 31059, France
-
Investigational Site Number : 3000001
Athens, 11528, Greece
-
Investigational Site Number : 7240001
Salamanca, Salamanca, 37007, Spain
-
Mayo Clinic of Rochester Site Number : 8400005
Rochester, Minnesota, 55905, United States
-
UNC Chapel Hill Site Number : 8400006
Chapel Hill, North Carolina, 27599, United States
Conditions
Explore the condition pages connected to this study.